Browse all categories:

Addiction Psychiatry in the NHS in the Time of Coronavirus

By Dr Tracey Myton MRCPsych Consultant Addiction Psychiatrist Greater Manchester Mental Health NHS Foundation Trust   March 2020 seems like a lifetime ago. Coronavirus came nearer and nearer and was viewed with varying degrees of gravity whilst we went about our daily business. In mid-March we were called to seriously consider how our services should  …


Parliamentary briefing on tackling the misuse of Nitrous Oxide

This Parliamentary briefing has been prepared by DrugScience, The Global Drug Survey, Release and Transform Drug Policy Foundation.   Recreational use of nitrous oxide Nitrous oxide is a gas that was discovered in the late 1800s by UK scientists Priestley and Davy, the latter being President of the Royal Society. At the time nitrous oxide  …


Medical MDMA Student Educational Slides

MDMA (3,4-Methyl​enedioxy​methamphetamine) was first synthesised in 1912 by chemists at the pharmaceutical company, Merck in Germany. In 1985, MDMA was placed in schedule 1, resulting in no research being conducted into the potential therapeutic applications of MDMA between 1985 – 2000. However, since then, MDMA has been included in over 5000 academic articles and administered to  …


Medical Psilocybin Student Educational Slides

The psychotropic effects of Psilocybe mushrooms were largely unknown in the West until the 1950s, despite evidence that they had a long history of indigenous use in Central and South America, and possibly other parts of the world. Western civilisations had very little knowledge of this relatively ‘new‘ psychotropic and subsequently banned research into its  …


New Zealand revises sentencing framework for methamphetamine offences

Dr James Foulds, Consultant forensic psychiatrist, Christchurch New Zealand Methamphetamine smoking is the commonest form of stimulant use in New Zealand. Asian importation has increased recently, and the drug has got much cheaper. However, despite harsh sanctions, dealing remains attractive for many people- including those who sell the drug to fund their own use. Until  …


Looking back on the establishment of Drug Science

I first came across David Nutt in July 2007, when he spoke at a conference called ‘Criminal Justice and Social Justice’, which the Centre for Crime and Justice Studies held at King’s College London. David spoke on the subject of ‘Why adopt a harm approach in relation to drugs?’. Here was someone, I thought at  …


NICE on cannabidiol for childhood epilepsy

At the end of last week, NICE released their initial appraisal on cannabidiol in the form of Epidiolex for childhood epilepsy.  As predicted by Drug Science experts they found against it on the grounds of cost-benefit. We don’t have the company submission regarding cost/benefit analysis, and consequently cannot comment on those, but we can reflect  …


Press Release: Government decision on cannabis-related medicinal products draws criticism from independent scientific body, Drug Science.

Today (13th August 2019), the independent scientific body Drug Science has responded with disappointment to a decision by the National Institute for Health and Care Excellence (NICE), relating to cannabis-related medical products. In November 2018, the then Home Secretary Sajid Javid introduced regulations so that cannabis-derived medicinal products would be available on prescription. This change  …